跳至主要内容
临床试验/CTRI/2024/04/064956
CTRI/2024/04/064956尚未招募4 期

To compare visual outcome, post-operative inflammation and Cystoid macular edema in Early v/s late initiation of NSAIDs

Mithila Pravin Joshi1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2024年4月8日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
220
试验地点
1
主要终点
Improvement in visual acuity

研究概览

简要总结

Post operative inflammation and Cystoid Macular Edema

(CME) are common complications following cataract surgery. Corticosteroids and Non-Steroidal

Anti-Inflammatory Drugs (NSAIDs) are commonly used to treat them. This study aims to compare

these complications after surgery with administration of the above mentioned two drugs. Patients

will be divided in two groups- Group 1 will receive topical Nepafenac 0.1% thrice daily for 1 month from

postoperative day 1. Group 2 will receive topical Nepafenac 0.1% thrice daily for 1 month starting 3 weeks

postoperatively. All participants will receive topical Dexamethasone 0.1% 6 times a day for 1 week, 4 times a

day for the next week, and then tapered 1 drop per week over the next 3 weeks from post operative day 1.

Both groups will be compared to look for post operative inflammation, CME and visual acuity after the

surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
45.00 Year(s) 至 75.00 Year(s)(—)
性别
All

入选标准

  • Visually significant cataract Uneventful phacoemulsification with IOL implantation.

排除标准

  • Diabetic retinopathy and other retinal pathologies 2)History of uveitis.
  • Mature, hyper mature, traumatic, complicated cataract.
  • Known or suspected hypersensitivity to Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) 5) Cystoid macular edema in the fellow eye.
  • Vascular occlusive disorders.
  • Associated Macular pathologies 8)Pregnant and lactating women 9) Patients with mental illness 10)Non visualization of fundus 11) H/O steroid responsiveness 12) H/O Prostaglandin analog usage 13) Dry eye.

结局指标

主要结局

Improvement in visual acuity

时间窗: 1 year

次要结局

  • 1)Reduced incidence of post operative inflammation.(2)Reduced incidence of CME on late initiation of prophylactic NSAID therapy.)

研究者

发起方
Mithila Pravin Joshi
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr.Mithila Pravin Joshi

Aravind Eye Hospitals , Chennai

研究点 (1)

Loading locations...

相似试验